1. Home
  2. CSBR vs LOAN Comparison

CSBR vs LOAN Comparison

Compare CSBR & LOAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSBR
  • LOAN
  • Stock Information
  • Founded
  • CSBR 1985
  • LOAN 1989
  • Country
  • CSBR United States
  • LOAN United States
  • Employees
  • CSBR N/A
  • LOAN N/A
  • Industry
  • CSBR Biotechnology: Biological Products (No Diagnostic Substances)
  • LOAN Real Estate Investment Trusts
  • Sector
  • CSBR Health Care
  • LOAN Real Estate
  • Exchange
  • CSBR Nasdaq
  • LOAN Nasdaq
  • Market Cap
  • CSBR 65.9M
  • LOAN 64.4M
  • IPO Year
  • CSBR 1986
  • LOAN 1999
  • Fundamental
  • Price
  • CSBR $4.42
  • LOAN $5.52
  • Analyst Decision
  • CSBR Strong Buy
  • LOAN
  • Analyst Count
  • CSBR 1
  • LOAN 0
  • Target Price
  • CSBR $6.00
  • LOAN N/A
  • AVG Volume (30 Days)
  • CSBR 16.8K
  • LOAN 27.4K
  • Earning Date
  • CSBR 12-10-2024
  • LOAN 10-22-2024
  • Dividend Yield
  • CSBR N/A
  • LOAN 8.33%
  • EPS Growth
  • CSBR N/A
  • LOAN 12.78
  • EPS
  • CSBR N/A
  • LOAN 0.50
  • Revenue
  • CSBR $51,655,000.00
  • LOAN $7,437,330.00
  • Revenue This Year
  • CSBR $9.27
  • LOAN N/A
  • Revenue Next Year
  • CSBR $9.76
  • LOAN N/A
  • P/E Ratio
  • CSBR N/A
  • LOAN $11.12
  • Revenue Growth
  • CSBR N/A
  • LOAN 9.69
  • 52 Week Low
  • CSBR $3.60
  • LOAN $4.27
  • 52 Week High
  • CSBR $7.13
  • LOAN $5.90
  • Technical
  • Relative Strength Index (RSI)
  • CSBR 45.62
  • LOAN 53.78
  • Support Level
  • CSBR $4.50
  • LOAN $5.21
  • Resistance Level
  • CSBR $4.74
  • LOAN $5.71
  • Average True Range (ATR)
  • CSBR 0.28
  • LOAN 0.18
  • MACD
  • CSBR -0.03
  • LOAN -0.00
  • Stochastic Oscillator
  • CSBR 20.33
  • LOAN 44.93

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

About LOAN Manhattan Bridge Capital Inc

Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.

Share on Social Networks: